Open AccessMetabolic effects of cross-sex hormone therapy in transgender individuals in Taiwan
Author(s) -
Yu-Hsien Liu,
Tsung-Hui Wu,
ChengHsin Chu,
YiChun Lin,
LiangYu Lin
Publication year - 2021
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000475
Subject(s) - medicine , body mass index , transgender , hormone therapy , sex hormone binding globulin , endocrinology , hormone , high density lipoprotein , incidence (geometry) , cholesterol , testosterone (patch) , metabolic syndrome , obesity , androgen , cancer , breast cancer , psychology , physics , psychoanalysis , optics
Transgender individuals often require gender-affirming interventions, such as endogenous sex hormone inhibition or gender-affirming hormone therapy (HT), while there is discordance between their body and gender identity. However, a recent study found that the incidence of cardiovascular events is higher in transgender patients receiving cross-sex HT. The aim of this study was to investigate the metabolic effects of an altered sex hormone profile.